A novel mutation of the MFN2 gene in a Chinese family with Charcot-Marie-Tooth disease

Genetics and Molecular Research

Volumn 11, Issue 2, 2012, Pages 1454-1459

  Wang, Y W ^a   Han, W T ^a   Jiang, M ^a   Lu, C X ^b   Li, X F ^a   Zhang, X ^b   Li, J X ^a  

^a Key Laboratory of Reproductive Health of Liaoning Province   (China)

^b INSTITUTE OF BASIC MEDICAL SCIENCES   (China)

Author keywords

Charcot Marie Tooth; Gender; Mitofusin 2; Mutation

Indexed keywords

MITOFUSIN 2;

AGED; AMINO ACID SUBSTITUTION; ARTICLE; CHINESE; CLINICAL ARTICLE; CODON; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; GENETIC ASSOCIATION; GENETIC LINKAGE; HEREDITARY MOTOR SENSORY NEUROPATHY; HUMAN; LEG DISEASE; LIMB WEAKNESS; MALE; MISSENSE MUTATION; MITOFUSIN 2 GENE; MUTATOR GENE; NUCLEOTIDE SEQUENCE; PHENOTYPE; POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS; SEX DIFFERENCE;

EID: 84930480464     PISSN: None     EISSN: 16765680     Source Type: Journal    
DOI: 10.4238/2012.May.18.5     Document Type: Article

References (13)

1. Banchs I, Casasnovas C, Montero J, Martinez-Matos JA, et al. (2008). Two Spanish families with Charcot-Marie-Tooth type 2A: clinical, electrophysiological and molecular findings. Neuromuscul. Disord. 18: 974-978.
2. Barisic N, Claeys KG, Sirotkovic-Skerlev M, Lofgren A, et al. (2008). Charcot-Marie-Tooth disease: a clinico-genetic confrontation. Ann. Hum. Genet. 72: 416-441.
3. Cartoni R and Martinou JC (2009). Role of mitofusin 2 mutations in the physiopathology of Charcot-Marie-Tooth disease type 2A. Exp. Neurol. 218: 268-273.
4. Chung KW, Kim SB, Park KD, Choi KG, et al. (2006). Early onset severe and late-onset mild Charcot-Marie-Tooth disease with mitofusin 2 (MFN2) mutations. Brain 129: 2103-2118.
5. Engelfried K, Vorgerd M, Hagedorn M, Haas G, et al. (2006). Charcot-Marie-Tooth neuropathy type 2A: novel mutations in the mitofusin 2 gene (MFN2). BMC Med. Genet. 7: 53.
6. Honda S, Aihara T, Hontani M, Okubo K, et al. (2005). Mutational analysis of action of mitochondrial fusion factor mitofusin-2. J. Cell Sci. 118: 3153-3161.
7. Kijima K, Numakura C, Izumino H, Umetsu K, et al. (2005). Mitochondrial GTPase mitofusin 2 mutation in Charcot-Marie-Tooth neuropathy type 2A. Hum. Genet. 116: 23-27.
8. Koshiba T, Detmer SA, Kaiser JT, Chen H, et al. (2004). Structural basis of mitochondrial tethering by mitofusin complexes. Science 305: 858-862.
9. Nicolaou P, Zamba-Papanicolaou E, Koutsou P, Kleopa KA, et al. (2010). Charcot-Marie-Tooth disease in Cyprus: epidemiological, clinical and genetic characteristics. Neuroepidemiology 35: 171-177.
10. Rojo M, Legros F, Chateau D and Lombes A (2002). Membrane topology and mitochondrial targeting of mitofusins, ubiquitous mammalian homologs of the transmembrane GTPase Fzo. J. Cell Sci. 115: 1663-1674.
11. Santel A and Fuller MT (2001). Control of mitochondrial morphology by a human mitofusin. J. Cell Sci. 114: 867-874.
12. Verhoeven K, Claeys KG, Zuchner S, Schroder JM, et al. (2006). MFN2 mutation distribution and genotype/phenotype correlation in Charcot-Marie-Tooth type 2. Brain 129: 2093-2102.
13. Züchner S, Mersiyanova IV, Muglia M, Bissar-Tadmouri N, et al. (2004). Mutations in the mitochondrial GTPase mitofusin 2 cause Charcot-Marie-Tooth neuropathy type 2A. Nat. Genet. 36: 449-451.